Easywell Biomedicals Stock Current Valuation
| 1799 Stock | TWD 72.40 0.70 0.96% |
Valuation analysis of Easywell Biomedicals helps investors to measure Easywell Biomedicals' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Easywell Biomedicals' price fluctuation is very steady at this time. Calculation of the real value of Easywell Biomedicals is based on 3 months time horizon. Increasing Easywell Biomedicals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Easywell stock is determined by what a typical buyer is willing to pay for full or partial control of Easywell Biomedicals. Since Easywell Biomedicals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Easywell Stock. However, Easywell Biomedicals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 72.4 | Real 59.16 | Hype 72.4 | Naive 71.41 |
The intrinsic value of Easywell Biomedicals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Easywell Biomedicals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Easywell Biomedicals helps investors to forecast how Easywell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Easywell Biomedicals more accurately as focusing exclusively on Easywell Biomedicals' fundamentals will not take into account other important factors: Easywell Biomedicals Company Current Valuation Analysis
Easywell Biomedicals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Easywell Biomedicals has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The current valuation for all Taiwan stocks is 100.0% higher than that of the company.
Easywell Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Easywell Biomedicals' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Easywell Biomedicals could also be used in its relative valuation, which is a method of valuing Easywell Biomedicals by comparing valuation metrics of similar companies.Easywell Biomedicals is currently under evaluation in current valuation category among its peers.
Easywell Fundamentals
| EBITDA | (140.2 M) | |||
| Net Income | (183.52 M) | |||
| Cash And Equivalents | 399.51 M | |||
| Cash Per Share | 3.49 X | |||
| Total Debt | 344.06 M | |||
| Debt To Equity | 0.41 % | |||
| Current Ratio | 6.64 X | |||
| Book Value Per Share | 7.01 X | |||
| Cash Flow From Operations | (102.55 M) | |||
| Earnings Per Share | (1.31) X | |||
| Number Of Employees | 11 | |||
| Beta | 0.93 | |||
| Market Capitalization | 1.2 B | |||
| Z Score | 1.8 | |||
| Last Dividend Paid | 1.79 |
About Easywell Biomedicals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Easywell Biomedicals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Easywell Biomedicals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Easywell Biomedicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Easywell Biomedicals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Easywell Biomedicals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Easywell Biomedicals will appreciate offsetting losses from the drop in the long position's value.Moving together with Easywell Stock
Moving against Easywell Stock
| 0.69 | 2345 | Accton Technology Corp | PairCorr |
| 0.68 | 0053 | YuantaP shares Taiwan | PairCorr |
| 0.67 | 0050 | YuantaP shares Taiwan | PairCorr |
| 0.65 | 0057 | Fubon MSCI Taiwan | PairCorr |
| 0.4 | 4129 | United Orthopedic | PairCorr |
The ability to find closely correlated positions to Easywell Biomedicals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Easywell Biomedicals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Easywell Biomedicals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Easywell Biomedicals to buy it.
The correlation of Easywell Biomedicals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Easywell Biomedicals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Easywell Biomedicals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Easywell Biomedicals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Easywell Stock Analysis
When running Easywell Biomedicals' price analysis, check to measure Easywell Biomedicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Easywell Biomedicals is operating at the current time. Most of Easywell Biomedicals' value examination focuses on studying past and present price action to predict the probability of Easywell Biomedicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Easywell Biomedicals' price. Additionally, you may evaluate how the addition of Easywell Biomedicals to your portfolios can decrease your overall portfolio volatility.